Cryptococcal fungemia and Mycobacterium haemophilum cellulitis in a patient receiving ruxolitinib: a case report and literature review

BACKGROUND: Ruxolitinib is a novel oral Janus kinase inhibitor that is used for treatment of myeloproliferative diseases. It exhibits potent anti-inflammatory and immunosuppressive effects, and may increase the risk of opportunistic infections. Here, we report a rare case of Cryptococcus neoformans...

Full description

Saved in:
Bibliographic Details
Published in:BMC Infect Dis
Main Authors: Sayabovorn, Naruemit, Chongtrakool, Piriyaporn, Chayakulkeeree, Methee
Format: Artigo
Language:Inglês
Published: BioMed Central 2021
Subjects:
Case Report
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7792301/
https://ncbi.nlm.nih.gov/pubmed/33413168
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12879-020-05703-2
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items